Celltrion Pharm Ranked High in Searches... Stock Price Down 8.97%
As of 12:32 PM on the 4th, Celltrion Pharm is trading at 217,200 KRW, down 8.97% from the previous day. This represents a 15.58% decline compared to December 28. Celltrion Pharm is known as a company specializing in pharmaceuticals and health supplements.
Today, foreigners are tentatively recorded as net buyers of 8,000 shares. Over the past five days, individual investors have been net sellers of 75,684 shares, while foreigners and institutions have been net buyers of 6,745 shares and 83,148 shares, respectively.
Hot Picks Today
As Samsung Falters, Chinese DRAM Surges: CXMT Returns to Profit in Just One Year
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- Iran Delivers New Ceasefire Proposal to U.S.; U.S. Says "Not Sufficient to Conclude Negotiations"
- Samsung Union Member Sparks Controversy With Telegram Post: "Let's Push KOSPI Down to 5,000"
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
